📊 Score Breakdown
Offering Ability
40
Cash Runway
65
Float Risk
35
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
26%
📉 Score Deterioration
40%
• Score rose 25 points recently (worsening)
💰 Capital Raise
15%
• Under 12 months cash (8mo)
🔄 Reverse Split
10%
• 8 months cash with weak price
💹 Market Data
Market Cap$45.80M
Shares Outstanding12.76M
Float8.61M
Cash$6.32M
Debt$59.1K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 0.2% shares (2025Q4 vs prior)
36 institutional holders · 2.34M shares
#1
BIOS Capital Management, LP
1.01M shares
#2
VANGUARD GROUP INC
384.0K shares
#3
CM Management, LLC
225.0K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest1.90M
Days to Cover5.3
% of Float22.1%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2024
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for LTRN
📊 LTRN FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 LTRN Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.